Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Incyte Corporation

Incyte Corporation

INCY · NASDAQ
INCY · NASDAQ

Next Earnings: 28 Jul 2025

71.25
USD0.050.07%

Latest News

    @MarketRebels
    MarketRebels

    STARTS NOW! Rebel's Edge 🏴‍☠️ 1pm Line up: Headline retail sales rose 0.2% #Copper up 19% YTD STOCKS $INCY $GES $AFRM $SAIC 🏈SPORTS: Brackets14 teams from the SEC!!! #NFL: Cinci making huge moves, problem is Bengals paying wrong players. 🚨 Record deal: Texans All-Pro CB Derek… https://t.co/lesaWFlCXr https://t.co/KVrFOmqwso

      SeekingAlpha

      Incyte gains amid takeover speculation

        SeekingAlpha

        Incyte seesaws on report of potential Merck takeover interest

          @Reuters
          Reuters

          FDA approves Incyte's treatment for chronic graft-versus-host disease https://t.co/UVkkA9nPRS https://t.co/yNUiXVa1fx

            SeekingAlpha

            Incyte to acquire immune-focused drug developer Escient

              SeekingAlpha

              Incyte buys global rights for tafasitamab from MorphoSys

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              70.15USD
              71.30USD

              52 Week Range

              53.56USD
              83.95USD

              Market Cap

              12.64BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US45337C1027

              CUSIP

              45337C102

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              339.14

              PEG Ratio

              0.13

              Book Value

              18.93

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              0.21

              Wall Street Target Price

              75.15

              EPS Estimate Current Year

              5.82

              EPS Estimate Next Year

              6.71

              EPS Estimate Current Quarter

              1.0486

              EPS Estimate Next Quarter

              1.4514

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              4,413,225,984

              Gross Profit TTM

              1,635,259,008

              EBITDA

              303,279,008

              Profit Margin

              0.48%

              Return On Assets TTM

              2.04%

              Return On Equity TTM

              0.47%

              Revenue Per Share TTM

              22.131

              Qtly Revenue Growth YOY

              19.50%

              Diluted Eps TTM

              0.21

              Qtly Earnings Growth YOY

              6.70%

              Valuation

              Trailing PE

              339.14

              Forward PE

              12

              Price Sales TTM

              3.1238

              Price Book MRQ

              3.7589

              Enterprise Value Revenue

              2

              Enterprise Value EBITDA

              28

              Peers analysis

              • CSL Limited
                CMXHFCSL Limited

                150.89

                1.50%
              • CSL Ltd
                CSLLYCSL Ltd

                78.41

                1.12%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                309.55

                0.53%
              • argenx SE
                ARGNFargenx SE

                586.54

                0.00%
              • Be
                ONCBeiGene, Ltd.

                264.42

                -1.93%
              • UCB SA ADR
                UCBJYUCB SA ADR

                93.37

                -0.63%
              • UCB SA
                UCBJFUCB SA

                195.59

                -0.61%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                520.00

                -0.54%
              • argenx NV ADR
                ARGXargenx NV ADR

                548.41

                -0.49%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                450.00

                -0.19%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Incyte Corporation stock price today?

              What is Incyte Corporation stock ticker?

              Is INCY stock price going up?

              What is the analyst recommendation for INCY?

              What is INCY market cap?

              Does INCY release financial reports?

              When is INCY next earnings date?

              What were INCY Earnings for the last quarter?

              What was INCY Revenue for the last quarter?

              What was INCY Net Income for the last quarter?

              Does INCY pay dividends?

              How many employees does INCY have?

              What is INCY EBITDA?

              How to buy INCY stocks?

              Should I invest in INCY stock?